Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,202 | 103,854 | 125,831 | 88,980 | 91,301 |
| Marketable Securities | 199,207 | 249,049 | 292,700 | 259,586 | 243,700 |
| Receivables | 7,245 | 8,243 | 5,744 | 9,653 | 13,412 |
| Inventories | 17,923 | 17,906 | 17,217 | 16,830 | 15,258 |
| TOTAL | $332,606 | $386,693 | $446,818 | $378,749 | $367,133 |
| Non-Current Assets | |||||
| PPE Net | 12,415 | 10,677 | 10,329 | 10,157 | 8,618 |
| Investments And Advances | 20,217 | 18,252 | 16,999 | 41,587 | 99,399 |
| Other Non-Current Assets | 5,726 | 5,742 | 5,962 | 10,907 | 11,009 |
| TOTAL | $38,358 | $34,671 | $33,290 | $62,651 | $119,026 |
| Total Assets | $370,964 | $421,364 | $480,108 | $441,400 | $486,159 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,745 | 3,644 | 5,085 | 5,924 | 5,623 |
| Accrued Expenses | 15,893 | 12,150 | 21,989 | 24,136 | 12,714 |
| TOTAL | $102,029 | $93,480 | $105,179 | $62,552 | $48,786 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 57,239 | 54,478 | 50,162 | 125 | 134 |
| Other Non-Current Liabilities | 252,873 | 252,607 | 260,099 | 258,566 | 249,968 |
| TOTAL | $282,380 | $293,497 | $311,522 | $263,670 | $253,256 |
| Total Liabilities | $384,409 | $386,977 | $416,701 | $326,222 | $302,042 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,411 | 55,104 | 54,854 | 54,381 | 54,103 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -961,959 | -902,526 | -861,708 | -797,740 | -710,818 |
| Other shareholders' equity | -331 | -525 | -854 | -733 | -292 |
| TOTAL | $-13,445 | $34,387 | $63,407 | $115,178 | $184,117 |
| Total Liabilities And Equity | $370,964 | $421,364 | $480,108 | $441,400 | $486,159 |